推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Theranostics

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 THERANOSTICS最新评论:哈哈哈,front挺贵的 (2024-03-26)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Theranostics期刊基本信息Hello,您是该期刊的第323550位访客

基本信息 登录收藏
期刊名字TheranosticsTheranostics

THERANOSTICS
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.4
71人评分
我要评分

声誉
8.9

影响力
7.9

速度
9.0

期刊ISSN1838-7640
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
12.4 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:12.478
2022-2023自引率1.60%点击查看自引率趋势图
五年影响因子12.3
h-index 69
CiteScore
CiteScoreSJRSNIPCiteScore排名
20.902.3811.893
学科分区排名百分位
大类:Medicine
小类:Medicine (miscellaneous)
Q15 / 309
大类:Medicine
小类:Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q11 / 32

期刊简介
Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications
期刊官方网站http://www.thno.org/
期刊投稿网址http://www.thno.org/ms/submit
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Theranostics的语言要求,还能让Theranostics编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Theranostics编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( AUD2500; )
文章处理费豁免:没有

其他费用:没有
期刊主题关键词:in vitro diagnostics and prognostics、in vivo molecular imaging、molecular therapeutics、image-guided therapy、biosensors、personalized medicine
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardPeer review
通讯方式PO BOX 4546, LAKE HAVEN, AUSTRALIA, NSW, 2263
出版商Ivyspring International Publisher
涉及的研究方向MEDICINE, RESEARCH & EXPERIMENTAL-
出版国家或地区AUSTRALIA
出版语言English
出版周期
出版年份2011
年文章数 431点击查看年文章数趋势图
Gold OA文章占比99.50%
研究类文章占比:
文章 ÷(文章 + 综述)
80.51%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL
类别:SCIE
Q18/136
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区4区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区3区1区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区4区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区1区1区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区4区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区2区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1838-7640%5BISSN%5D
平均审稿速度网友分享经验:
平均1月
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Theranostics顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Theranostics期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Theranostics中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Theranostics上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE604275
    BIOMATERIALS515895
    BIOMEDICINE & PHARMACOTHERAPY467022
    Journal of Materials Chemistry B461381
    Frontiers in Pharmacology452294
    Frontiers in Immunology423924
    JOURNAL OF ETHNOPHARMACOLOGY407567
    COLLOIDS AND SURFACES B-BIOINTERFACES405363
    Frontiers in Oncology385880
    Acta Biomaterialia377491
  •  

    Theranostics Theranostics
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Low-dose X-ray radiodynamic therapy solely based on gold nanoclusters for efficient treatment of deep hypoxic solid tumors combined with enhanced antitumor immune response

    Author: Zhu, Shengcang; Yan, Feihong; Yang, Lulu; Li, Bingyi; Xue, Ruxian; Yu, Wenwen; Wang, Yu; Huang, Lu; Wang, Lijun; Han, Rongcheng; Jiang, Yuqiang
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 3, pp. 1042-1058. DOI: 10.7150/thno.78649
        PubMed      DOI
    2.Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification

    Author: Zhao, Yu; Wen, Simeng; Li, Hang; Pan, Chun-Wu; Wei, Yulei; Huang, Ting; Li, Zhaochen; Yang, Yinhui; Fan, Saijun; Zhang, Yingyi
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 2, pp. 596-610. DOI: 10.7150/thno.78687
        PubMed      DOI
    3.Hyperactive neuronal autophagy depletes BDNF and impairs adult hippocampal neurogenesis in a corticosterone-induced mouse model of depression

    Author: Zhang, Kuo; Wang, Fan; Zhai, Mengying; He, Meiyao; Hu, Yuxuan; Feng, Lijin; Li, Yuting; Yang, Jingyu; Wu, Chunfu
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 3, pp. 1059-1075. DOI: 10.7150/thno.81067
        PubMed      DOI
    4.3,4-Dimethoxychalcone, a caloric restriction mimetic, enhances TFEB-mediated autophagy and alleviates pyroptosis and necroptosis after spinal cord injury

    Author: Zhang, Haojie; Ni, Wenfei; Yu, Gaoxiang; Geng, Yibo; Lou, Junsheng; Qi, Jianjun; Chen, Yituo; Li, Feida; Ye, Hantao; Ma, Haiwei; Xu, Hui; Zhao, Luying; Cai, Yuepiao; Wang, Xiangyang; Xu, Huazi; Xiao, Jian; Zhou, Kailiang
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 2, pp. 810-832. DOI: 10.7150/thno.78370
        PubMed      DOI
    5.Sigma-1 receptor-regulated efferocytosis by infiltrating circulating macrophages/microglial cells protects against neuronal impairments and promotes functional recovery in cerebral ischemic stroke

    Author: Zhang, Gufang; Li, Qi; Tao, Weijie; Qin, Pingping; Chen, Jiali; Yang, Huicui; Chen, Jiaojiao; Liu, Hua; Dai, Qijun; Zhen, Xuechu
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 2, pp. 543-559. DOI: 10.7150/thno.77088
        PubMed      DOI
    6.Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer

    Author: Zhang, Fang -Lin; Yang, Shao-Ying; Liao, Li; Zhang, Tai-Mei; Zhang, Yin -Ling; Hu, Shu-Yuan; Deng, Ling; Huang, Min-Ying; Andriani, Lisa; Ma, Xiao-Yan; Shao, Zhi-Min; Li, Da-Qiang
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 3, pp. 973-990. DOI: 10.7150/thno.79688
        PubMed      DOI
    7.Ablation of NLRP3 inflammasome attenuates muscle atrophy via inhibiting pyroptosis, proteolysis and apoptosis denervation

    Author: You, Zongqi; Huang, Xinying; Xiang, Yaoxian; Dai, Junxi; Xu, Lei; Jiang, Junjian; Xu, Jianguang
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 1, pp. 374-390. DOI: 10.7150/thno.74831
        PubMed      DOI
    8.Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer?s disease

    Author: Yin, Tong; Liu, Yan; Ji, Wenbo; Zhuang, Jianhua; Chen, Xiaohan; Gong, Baofeng; Chu, Jianjian; Liang, Wendanqi; Gao, Jie; Yin, You
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 3, pp. 1264-1285. DOI: 10.7150/thno.81860
        PubMed      DOI
    9.Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy

    Author: Yang, Jie; Dai, Dihua; Zhang, Xi; Teng, Lesheng; Ma, Lianjun; Yang, Ying-Wei
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 1, pp. 295-323. DOI: 10.7150/thno.80687
        PubMed      DOI
    10.Simplified one-pot 18F-labeling of biomolecules with in situ generated fluorothiophosphate synthons in high molar activity

    Author: Yang, Hongzhang; Zhang, Lei; Liu, Huanhuan; Zhang, Yunming; Mou, Zhaobiao; Chen, Xueyuan; Li, Jingchao; He, Fengming; Li, Zijing
    Journal: THERANOSTICS. 2023; Vol. 13, Issue 2, pp. 472-482. DOI: 10.7150/thno.79452
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共715条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451